Title 201 | Chapter 020 | Regulation 490REG
PROPOSED
This document is not yet current.
PREVIOUS VERSION
The previous document that this document is based upon is available.
Technical Amendment: 11/21/2023
201 KAR 20:490.Licensed practical nurse infusion therapy scope of practice.
Section 1.
Definitions.(1)
"Administration" means to initiate and maintain infusion therapy.(2)
"Antineoplastic agent" means a medication that prevents the development, growth, or proliferation of malignant cells.(3)
"Central venous access device" means a catheter inserted into a peripheral or centrally located vein with the tip residing in the superior or inferior vena cava. This includes peripherally inserted central catheters.(4)
"Direction" means a communication of a plan of care that is based upon assessment of a patient by an advanced practice registered nurse, a registered nurse, physician assistant, licensed physician, or dentist that establishes the parameters for the provision of care or for the performance of a procedure.(5)
"Peripheral venous access device" means a peripherally-inserted intravenous catheter or needle that is less than or equal to three (3) inches in length.(6)
"Pharmacology" means information on the classification of intravenous drugs, indications for use, pharmacological properties, monitoring parameters, contraindications, dosing, clinical mathematics, anticipated side effects, potential complications, antidotal therapy, compatibilities, stabilities, specific considerations for select intravenous drugs, and administration of intravenous medications to pediatric, adult, and geriatric populations.(7)
"Procedural sedation" means the administration of intravenous medications to produce a decreased level of consciousness.(8)
"Supervision" means the provision of guidance by a registered nurse, advanced practice registered nurse, physician assistant, licensed physician, or dentist for the accomplishment of a nursing task with periodic observation and evaluation of the performance of the task including validation that the nursing task has been performed in a safe manner.(9)
"Supervisor" means the registered nurse, advanced practice registered nurse, physician assistant, licensed physician, or dentist who provides supervision of the licensed practical nurse's practice as defined in this section.(10)
"Therapeutic phlebotomy" means removal of a specific volume of blood from a patient as ordered for the treatment of a specific condition or disease.(11)
"Unstable" means inconsistent, unpredictable, or consistently fluctuating.Section 2.
Education and Training Standards.(1)
Prior to performing infusion therapy, the licensed practical nurse (LPN) shall have completed education and training related to the scope of infusion therapy for an LPN. This education and training shall be obtained through:(a)
A prelicensure program of nursing for individuals admitted to the program after September 15, 2019; or(b)
An institution, practice setting, or continuing education provider that has in place a written instructional program and a competency validation mechanism that includes a process for evaluation and documentation of an LPN's demonstration of the knowledge, skills, and abilities related to the safe administration of infusion therapy. The LPN shall receive and maintain written documentation of completion of the instructional program and competency validation.(2)
The education and training programs recognized in subsection (1) of this section shall be based on the Policies and Procedures for Infusion Therapy: Home Infusion and the Infusion Therapy: Standards of Practice and shall include the following components:(a)
Legal considerations and risk management issues;(b)
Related anatomy and physiology including fluid and electrolyte balance;(c)
Principles of pharmacology as related to infusion therapy;(d)
Infusion equipment and preparation;(e)
Principles and procedures for administration of solutions and medications via intravenous route including transfusion therapy and parenteral nutrition;(f)
Principles and procedures for site maintenance for a peripheral venous access device and a central venous access device;(g)
Assessment of and appropriate interventions for complications related to infusion therapy; and(h)
Demonstration and validation of competency for infusion therapy procedures.Section 3.
Supervision Requirements.(1)
An LPN performing infusion therapy procedures shall be under the direction and supervision of a registered nurse (RN), advanced practice registered nurse (APRN), physician assistant, licensed physician, or dentist.(2)
For a patient whose condition is determined by the LPN's supervisor to be stable and predictable, and rapid change is not anticipated, the supervisor may provide supervision of the LPN's provision of infusion therapy without being physically present in the immediate vicinity of the LPN, but shall be readily available.(3)
In the following cases, for the LPN to provide infusion therapy, the LPN's supervisor shall be physically present in the immediate vicinity of the LPN and immediately available to intervene in the care of the patient:(a)
If a patient's condition is or becomes unstable;(b)
If a patient is receiving blood, blood components, or plasma volume expanders; or(c)
If a patient is receiving peritoneal dialysis or hemodialysis.Section 4.
Standards of Practice.(1)
An LPN shall perform only those infusion therapy acts for which the LPN possesses the knowledge, skill, and ability to perform in a safe manner, except as limited by Section 5 of this administrative regulation and under supervision as required by Section 3 of this administrative regulation.(2)
An LPN shall consult with an RN or physician, physician assistant, dentist, or advanced practice registered nurse and seek guidance as needed if:(a)
The patient's care needs exceed the licensed practical nursing scope of practice;(b)
The patient's care needs surpass the LPN's knowledge, skill, or ability; or(c)
The patient's condition becomes unstable.(3)
An LPN shall obtain instruction and supervision as necessary if implementing new or unfamiliar nursing practices or procedures.(4)
An LPN shall follow the written, established policies and procedures of the facility that are consistent with KRS Chapter 314.Section 5.
Functions That Shall Not Be Performed. An LPN shall not perform the following infusion therapy functions:(1)
Administration of tissue plasminogen activators, except when used to declot any central venous access device;(2)
Accessing of a central venous access device used for hemodynamic monitoring;(3)
Administration of medications or fluids via arterial lines or implanted arterial ports;(4)
Accessing or programming an implanted infusion pump;(5)
Administration of infusion therapy medications for the purpose of procedural sedation or anesthesia;(6)
Administration of fluids or medications via an epidural, intrathecal, intraosseous, or umbilical route, or via a ventricular reservoir;(7)
Administration of medications or fluids via an arteriovenous fistula or graft, except for dialysis;(8)
Repair of a central venous access device;(9)
Performance of therapeutic phlebotomy;(10)
Aspiration of an arterial line;(11)
Initiation and removal of a peripherally inserted central, midclavicular, or midline catheter; or(12)
Administration of immunoglobulins, antineoplastic agents, or investigational drugs.Section 6.
Incorporation by Reference.(1)
The following material is incorporated by reference:(a)
"Policies and Procedures for Infusion Therapy: Home Infusion", Infusion Nurses Society, Second Edition, 2021; and(b)
"Infusion Therapy: Standards of Practice", Infusion Nurses Society, Eighth Edition, 2021.(2)
This material may be inspected, copied, or obtained, subject to applicable copyright law, at the Board of Nursing, 312 Whittington Parkway, Suite 300, Louisville, Kentucky, Monday through Friday, 8 a.m. to 4:30 p.m. Links to this material is also available on the board's Web site at https://kbn.ky.gov/document-library/Pages/default.aspxHISTORY: (30 Ky.R. 2585; 31 Ky.R. 369; 546; eff. 9-15-2004; 32 Ky.R. 2324; 33 Ky.R. 382; eff. 9-1-2006; 36 Ky.R. 2073-A; 2312; eff. 6-15-2010; TAm eff. 7-15-2010; 37 Ky.R. 2446; 2830; eff. 6-15-2011; 38 Ky.R. 1764; 1945; eff. 6-20-2012; 45 Ky.R. 415, 948; eff. 11-2-2018; 49 Ky.R. 420, 1056; eff. 11-15-2022; TAm eff. 11-21-2023.)
Technical Amendment: 11/21/2023
201 KAR 20:490.Licensed practical nurse infusion therapy scope of practice.
Section 1.
Definitions.(1)
"Administration" means to initiate and maintain infusion therapy.(2)
"Antineoplastic agent" means a medication that prevents the development, growth, or proliferation of malignant cells.(3)
"Central venous access device" means a catheter inserted into a peripheral or centrally located vein with the tip residing in the superior or inferior vena cava. This includes peripherally inserted central catheters.(4)
"Direction" means a communication of a plan of care that is based upon assessment of a patient by an advanced practice registered nurse, a registered nurse, physician assistant, licensed physician, or dentist that establishes the parameters for the provision of care or for the performance of a procedure.(5)
"Peripheral venous access device" means a peripherally-inserted intravenous catheter or needle that is less than or equal to three (3) inches in length.(6)
"Pharmacology" means information on the classification of intravenous drugs, indications for use, pharmacological properties, monitoring parameters, contraindications, dosing, clinical mathematics, anticipated side effects, potential complications, antidotal therapy, compatibilities, stabilities, specific considerations for select intravenous drugs, and administration of intravenous medications to pediatric, adult, and geriatric populations.(7)
"Procedural sedation" means the administration of intravenous medications to produce a decreased level of consciousness.(8)
"Supervision" means the provision of guidance by a registered nurse, advanced practice registered nurse, physician assistant, licensed physician, or dentist for the accomplishment of a nursing task with periodic observation and evaluation of the performance of the task including validation that the nursing task has been performed in a safe manner.(9)
"Supervisor" means the registered nurse, advanced practice registered nurse, physician assistant, licensed physician, or dentist who provides supervision of the licensed practical nurse's practice as defined in this section.(10)
"Therapeutic phlebotomy" means removal of a specific volume of blood from a patient as ordered for the treatment of a specific condition or disease.(11)
"Unstable" means inconsistent, unpredictable, or consistently fluctuating.Section 2.
Education and Training Standards.(1)
Prior to performing infusion therapy, the licensed practical nurse (LPN) shall have completed education and training related to the scope of infusion therapy for an LPN. This education and training shall be obtained through:(a)
A prelicensure program of nursing for individuals admitted to the program after September 15, 2019; or(b)
An institution, practice setting, or continuing education provider that has in place a written instructional program and a competency validation mechanism that includes a process for evaluation and documentation of an LPN's demonstration of the knowledge, skills, and abilities related to the safe administration of infusion therapy. The LPN shall receive and maintain written documentation of completion of the instructional program and competency validation.(2)
The education and training programs recognized in subsection (1) of this section shall be based on the Policies and Procedures for Infusion Therapy: Home Infusion and the Infusion Therapy: Standards of Practice and shall include the following components:(a)
Legal considerations and risk management issues;(b)
Related anatomy and physiology including fluid and electrolyte balance;(c)
Principles of pharmacology as related to infusion therapy;(d)
Infusion equipment and preparation;(e)
Principles and procedures for administration of solutions and medications via intravenous route including transfusion therapy and parenteral nutrition;(f)
Principles and procedures for site maintenance for a peripheral venous access device and a central venous access device;(g)
Assessment of and appropriate interventions for complications related to infusion therapy; and(h)
Demonstration and validation of competency for infusion therapy procedures.Section 3.
Supervision Requirements.(1)
An LPN performing infusion therapy procedures shall be under the direction and supervision of a registered nurse (RN), advanced practice registered nurse (APRN), physician assistant, licensed physician, or dentist.(2)
For a patient whose condition is determined by the LPN's supervisor to be stable and predictable, and rapid change is not anticipated, the supervisor may provide supervision of the LPN's provision of infusion therapy without being physically present in the immediate vicinity of the LPN, but shall be readily available.(3)
In the following cases, for the LPN to provide infusion therapy, the LPN's supervisor shall be physically present in the immediate vicinity of the LPN and immediately available to intervene in the care of the patient:(a)
If a patient's condition is or becomes unstable;(b)
If a patient is receiving blood, blood components, or plasma volume expanders; or(c)
If a patient is receiving peritoneal dialysis or hemodialysis.Section 4.
Standards of Practice.(1)
An LPN shall perform only those infusion therapy acts for which the LPN possesses the knowledge, skill, and ability to perform in a safe manner, except as limited by Section 5 of this administrative regulation and under supervision as required by Section 3 of this administrative regulation.(2)
An LPN shall consult with an RN or physician, physician assistant, dentist, or advanced practice registered nurse and seek guidance as needed if:(a)
The patient's care needs exceed the licensed practical nursing scope of practice;(b)
The patient's care needs surpass the LPN's knowledge, skill, or ability; or(c)
The patient's condition becomes unstable.(3)
An LPN shall obtain instruction and supervision as necessary if implementing new or unfamiliar nursing practices or procedures.(4)
An LPN shall follow the written, established policies and procedures of the facility that are consistent with KRS Chapter 314.Section 5.
Functions That Shall Not Be Performed. An LPN shall not perform the following infusion therapy functions:(1)
Administration of tissue plasminogen activators, except when used to declot any central venous access device;(2)
Accessing of a central venous access device used for hemodynamic monitoring;(3)
Administration of medications or fluids via arterial lines or implanted arterial ports;(4)
Accessing or programming an implanted infusion pump;(5)
Administration of infusion therapy medications for the purpose of procedural sedation or anesthesia;(6)
Administration of fluids or medications via an epidural, intrathecal, intraosseous, or umbilical route, or via a ventricular reservoir;(7)
Administration of medications or fluids via an arteriovenous fistula or graft, except for dialysis;(8)
Repair of a central venous access device;(9)
Performance of therapeutic phlebotomy;(10)
Aspiration of an arterial line;(11)
Initiation and removal of a peripherally inserted central, midclavicular, or midline catheter; or(12)
Administration of immunoglobulins, antineoplastic agents, or investigational drugs.Section 6.
Incorporation by Reference.(1)
The following material is incorporated by reference:(a)
"Policies and Procedures for Infusion Therapy: Home Infusion", Infusion Nurses Society, Second Edition, 2021; and(b)
"Infusion Therapy: Standards of Practice", Infusion Nurses Society, Eighth Edition, 2021.(2)
This material may be inspected, copied, or obtained, subject to applicable copyright law, at the Board of Nursing, 312 Whittington Parkway, Suite 300, Louisville, Kentucky, Monday through Friday, 8 a.m. to 4:30 p.m. Links to this material is also available on the board's Web site at https://kbn.ky.gov/document-library/Pages/default.aspxHISTORY: (30 Ky.R. 2585; 31 Ky.R. 369; 546; eff. 9-15-2004; 32 Ky.R. 2324; 33 Ky.R. 382; eff. 9-1-2006; 36 Ky.R. 2073-A; 2312; eff. 6-15-2010; TAm eff. 7-15-2010; 37 Ky.R. 2446; 2830; eff. 6-15-2011; 38 Ky.R. 1764; 1945; eff. 6-20-2012; 45 Ky.R. 415, 948; eff. 11-2-2018; 49 Ky.R. 420, 1056; eff. 11-15-2022; TAm eff. 11-21-2023.)